COMPLETE TEST BANK FOR
PHARMACOLOGY: A PATIENT-CENTERED NURSING PROCESS
APPROACH 10TH EDITION
BY LINDA E. MCCUISTION|CHAPTERS 1-55|CORRECT ANSWERS
,Table of Contents
Chapter 01:The Nursing Process And Patient-Centered Care ..................................................................... 4
Chapter 02: Drug Development And Ethical Considerations .................................................................... 11
Chapter 03: Pharmacokinetics, Pharmacodynamics, And Pharmacogenetics ......................................... 21
Chapter 04: Pharmacogenetics .................................................................................................................. 40
Chapter 05: Complementary And Alternative Therapies .......................................................................... 44
Chapter 06: Pediatric Considerations ........................................................................................................ 50
Chapter 07: Geriatric Considerations......................................................................................................... 58
Chapter 08: Drugs Of Abuse ....................................................................................................................... 65
Chapter 09: Safety And Quality ................................................................................................................. 72
Chapter 10: Drug Administration............................................................................................................... 79
Chapter 11: Drug Calculations .................................................................................................................... 85
Chapter 12: Fluid Volume And Electrolytes ................................................................................................ 91
Chapter 13: Vitamin And Mineral Replacement ....................................................................................... 102
Chapter 14: Nutritional Support ............................................................................................................... 111
Chapter 15: Adrenergic Agonists And Antagonists ................................................................................... 120
Chapter 16: Cholinergic Agonists And Antagonists .................................................................................. 128
Chapter 17: Stimulants ............................................................................................................................. 136
Chapter 18: Depressants ........................................................................................................................... 141
Chapter 19: Antiseizure Drugs .................................................................................................................. 149
Chapter 20: Drugs For Parkinson Disease And Alzheimer Disease ........................................................... 158
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms .................................................... 166
Chapter 22: Antipsychotics And Anxiolytics ............................................................................................. 173
Chapter 23: Antidepressants And Mood Stabilizers ................................................................................. 182
Chapter 24: Antiinflammatories ............................................................................................................... 191
Chapter 25: Analgesics .............................................................................................................................. 200
Chapter 26: Antibacterials ........................................................................................................................ 208
Chapter 27: Antituberculars, Antifungals, And Antivirals ......................................................................... 229
Chapter 28: Peptides, Antimalarials, And Anthelmintics .......................................................................... 240
Chapter 29: HIV- And AIDS-Related Drugs ................................................................................................ 244
Chapter 30: Transplant Drugs ................................................................................................................... 249
Chapter 31: Vaccines................................................................................................................................. 252
Chapter 32: Anticancer Drugs ................................................................................................................... 257
,Chapter 33: Targeted Therapies To Treat Cancer ..................................................................................... 263
Chapter 34: Biologic Response Modifiers ................................................................................................. 267
Chapter 35: Upper Respiratory Disorders................................................................................................. 272
Chapter 36: Lower Respiratory Disorders ................................................................................................. 277
Chapter 37: Cardiac Glycosides, Antianginals, And Antidysrhythmics ..................................................... 285
Chapter 38: Diuretics ................................................................................................................................ 294
Chapter 39: Antihypertensives ................................................................................................................. 299
Chapter 40: Anticoagulants, Antiplatelets, And Thrombolytics................................................................ 307
Chapter 41: Antihyperlipidemics And Peripheral Vasodilators ................................................................ 315
Chapter 42: Gastrointestinal Tract Disorders ........................................................................................... 321
Chapter 43: Antiulcer Drugs...................................................................................................................... 329
Chapter 44: Eye And Ear Disorders ........................................................................................................... 337
Chapter 45: Dermatologic Disorders ........................................................................................................ 342
Chapter 46: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders ....................................................... 347
Chapter 47: Antidiabetics ......................................................................................................................... 356
Chapter 48: Urinary Disorders .................................................................................................................. 364
Chapter 49: Pregnancy And Preterm Labor .............................................................................................. 370
Chapter 50: Labor, Delivery, And Postpartum .......................................................................................... 378
Chapter 51: Neonatal And Newborn ........................................................................................................ 384
Chapter 52: Women’s Reproductive Health ............................................................................................. 386
Chapter 53: Men’s Reproductive Health .................................................................................................. 394
Chapter 54: Sexually Transmitted Infections ............................................................................................ 399
Chapter 55: Adult And Pediatric Emergency Drugs .................................................................................. 402
, Chapter 01:The Nursing Process And Patient-Centered Care
Mccuistion: Pharmacology: A Patient-Centered Nursing Process Approach,
10th Edition
MULTIPLE CHOICE
1. The Nursing Process Is A Five-Step Decision-Making Approach That Includes All Of The Following
Steps, EXCEPT:
A. Assessment
B. Patient Problem
C. Planning
D. Right Drug
ANS: D
The Nursing Process Is A Five-Step Decision-Making Approach That Includes: 1) Assessment, 2) Patient
Problem, 3) Planning, 4) Implementation, And 5) Evaluation. “Right Drug” Is One Of The “Six Rights” Of
Medication Administration.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning MSC:
NCLEX: Management Of Care
2. The Nurse Is Using Data Collected To Set Goals Or Expected Outcomes And Interventions That
Address The Patient’s Problems. Which Step Of The Nursing Process Is The Nurse Applying?
A. Assessment
B. Patient Problem
C. Planning
D. Evaluation
ANS: C
During The Planning Phase, The Nurse Uses The Data Collected To Set Goals Or Expected Outcomes And
Interventions Which Address The Patient’s Problems. The Data Was Collected During The “Assessment”
And “Patient Problem” Steps. During The “Evaluation” Phase The Nurse Would Determine Whether The
Goals And Objectives Set During The Planning Phase Were Met.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management Of Care
3. A 5-Year-Old Child With Type 1 Diabetes Mellitus Has Had Repeated Hospitalizations For
Episodes Of Hyperglycemia. The Parents Tell The Nurse That They Can’t Keep Track Of Everything That
PHARMACOLOGY: A PATIENT-CENTERED NURSING PROCESS
APPROACH 10TH EDITION
BY LINDA E. MCCUISTION|CHAPTERS 1-55|CORRECT ANSWERS
,Table of Contents
Chapter 01:The Nursing Process And Patient-Centered Care ..................................................................... 4
Chapter 02: Drug Development And Ethical Considerations .................................................................... 11
Chapter 03: Pharmacokinetics, Pharmacodynamics, And Pharmacogenetics ......................................... 21
Chapter 04: Pharmacogenetics .................................................................................................................. 40
Chapter 05: Complementary And Alternative Therapies .......................................................................... 44
Chapter 06: Pediatric Considerations ........................................................................................................ 50
Chapter 07: Geriatric Considerations......................................................................................................... 58
Chapter 08: Drugs Of Abuse ....................................................................................................................... 65
Chapter 09: Safety And Quality ................................................................................................................. 72
Chapter 10: Drug Administration............................................................................................................... 79
Chapter 11: Drug Calculations .................................................................................................................... 85
Chapter 12: Fluid Volume And Electrolytes ................................................................................................ 91
Chapter 13: Vitamin And Mineral Replacement ....................................................................................... 102
Chapter 14: Nutritional Support ............................................................................................................... 111
Chapter 15: Adrenergic Agonists And Antagonists ................................................................................... 120
Chapter 16: Cholinergic Agonists And Antagonists .................................................................................. 128
Chapter 17: Stimulants ............................................................................................................................. 136
Chapter 18: Depressants ........................................................................................................................... 141
Chapter 19: Antiseizure Drugs .................................................................................................................. 149
Chapter 20: Drugs For Parkinson Disease And Alzheimer Disease ........................................................... 158
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms .................................................... 166
Chapter 22: Antipsychotics And Anxiolytics ............................................................................................. 173
Chapter 23: Antidepressants And Mood Stabilizers ................................................................................. 182
Chapter 24: Antiinflammatories ............................................................................................................... 191
Chapter 25: Analgesics .............................................................................................................................. 200
Chapter 26: Antibacterials ........................................................................................................................ 208
Chapter 27: Antituberculars, Antifungals, And Antivirals ......................................................................... 229
Chapter 28: Peptides, Antimalarials, And Anthelmintics .......................................................................... 240
Chapter 29: HIV- And AIDS-Related Drugs ................................................................................................ 244
Chapter 30: Transplant Drugs ................................................................................................................... 249
Chapter 31: Vaccines................................................................................................................................. 252
Chapter 32: Anticancer Drugs ................................................................................................................... 257
,Chapter 33: Targeted Therapies To Treat Cancer ..................................................................................... 263
Chapter 34: Biologic Response Modifiers ................................................................................................. 267
Chapter 35: Upper Respiratory Disorders................................................................................................. 272
Chapter 36: Lower Respiratory Disorders ................................................................................................. 277
Chapter 37: Cardiac Glycosides, Antianginals, And Antidysrhythmics ..................................................... 285
Chapter 38: Diuretics ................................................................................................................................ 294
Chapter 39: Antihypertensives ................................................................................................................. 299
Chapter 40: Anticoagulants, Antiplatelets, And Thrombolytics................................................................ 307
Chapter 41: Antihyperlipidemics And Peripheral Vasodilators ................................................................ 315
Chapter 42: Gastrointestinal Tract Disorders ........................................................................................... 321
Chapter 43: Antiulcer Drugs...................................................................................................................... 329
Chapter 44: Eye And Ear Disorders ........................................................................................................... 337
Chapter 45: Dermatologic Disorders ........................................................................................................ 342
Chapter 46: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders ....................................................... 347
Chapter 47: Antidiabetics ......................................................................................................................... 356
Chapter 48: Urinary Disorders .................................................................................................................. 364
Chapter 49: Pregnancy And Preterm Labor .............................................................................................. 370
Chapter 50: Labor, Delivery, And Postpartum .......................................................................................... 378
Chapter 51: Neonatal And Newborn ........................................................................................................ 384
Chapter 52: Women’s Reproductive Health ............................................................................................. 386
Chapter 53: Men’s Reproductive Health .................................................................................................. 394
Chapter 54: Sexually Transmitted Infections ............................................................................................ 399
Chapter 55: Adult And Pediatric Emergency Drugs .................................................................................. 402
, Chapter 01:The Nursing Process And Patient-Centered Care
Mccuistion: Pharmacology: A Patient-Centered Nursing Process Approach,
10th Edition
MULTIPLE CHOICE
1. The Nursing Process Is A Five-Step Decision-Making Approach That Includes All Of The Following
Steps, EXCEPT:
A. Assessment
B. Patient Problem
C. Planning
D. Right Drug
ANS: D
The Nursing Process Is A Five-Step Decision-Making Approach That Includes: 1) Assessment, 2) Patient
Problem, 3) Planning, 4) Implementation, And 5) Evaluation. “Right Drug” Is One Of The “Six Rights” Of
Medication Administration.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning MSC:
NCLEX: Management Of Care
2. The Nurse Is Using Data Collected To Set Goals Or Expected Outcomes And Interventions That
Address The Patient’s Problems. Which Step Of The Nursing Process Is The Nurse Applying?
A. Assessment
B. Patient Problem
C. Planning
D. Evaluation
ANS: C
During The Planning Phase, The Nurse Uses The Data Collected To Set Goals Or Expected Outcomes And
Interventions Which Address The Patient’s Problems. The Data Was Collected During The “Assessment”
And “Patient Problem” Steps. During The “Evaluation” Phase The Nurse Would Determine Whether The
Goals And Objectives Set During The Planning Phase Were Met.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management Of Care
3. A 5-Year-Old Child With Type 1 Diabetes Mellitus Has Had Repeated Hospitalizations For
Episodes Of Hyperglycemia. The Parents Tell The Nurse That They Can’t Keep Track Of Everything That
